Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma (DLBCL) is a fast-growing type of non-Hodgkin lymphoma that affects B-cells, leading to symptoms like swollen lymph nodes, fever, and weight loss.
We are studying a combination of two medications for patients with relapsed or refractory diffuse large B-cell lymphoma. The goal is to see how well this treatment works and its safety compared to existing options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Diffuse Large B-Cell Lymphoma (DLBCL) is a fast-growing type of non-Hodgkin lymphoma that affects B-cells, leading to symptoms like swollen lymph nodes, fever, and weight loss.
Follicular Lymphoma (FL) Grade 3B is a type of non-Hodgkin lymphoma that is generally slow-growing but can transform into a more aggressive form, causing symptoms like swollen lymph nodes and fatigue.
High-Grade B-Cell Lymphoma (HGBL) is a rapidly progressing form of lymphoma that affects B-cells, often presenting with symptoms such as swollen lymph nodes, fever, and significant weight loss.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.